Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Successful Systemic and Topical Treatment of Mycobacterium abscessus Otomastoiditis.

van Wijk F, Waterval J, van Aerde K, Henriet SSV, Meijer FJA, Borra LC, Aarnoutse RE, van Ingen J.

Antimicrob Agents Chemother. 2019 Dec 20;64(1). pii: e01203-19. doi: 10.1128/AAC.01203-19. Print 2019 Dec 20.

PMID:
31611360
2.

Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.

Ariëns LFM, van der Schaft J, Bakker DS, Balak D, Romeijn MLE, Kouwenhoven T, Kamsteeg M, Giovannone B, Drylewicz J, van Amerongen CCA, Delemarre EM, Knol EF, van Wijk F, Nierkens S, Thijs JL, Schuttelaar MLA, de Bruin-Weller MS.

Allergy. 2020 Jan;75(1):116-126. doi: 10.1111/all.14080. Epub 2019 Oct 31.

PMID:
31593343
3.

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases.

Mijnheer G, van Wijk F.

Front Immunol. 2019 May 9;10:940. doi: 10.3389/fimmu.2019.00940. eCollection 2019. Review.

4.

The identification of CCL18 as biomarker of disease activity in localized scleroderma.

Mertens JS, de Jong EMGJ, van den Hoogen LL, Wienke J, Thurlings RM, Seyger MMB, Hoppenreijs EPAH, Wijngaarde CA, van Vlijmen-Willems IMJJ, van den Bogaard E, Giovannone B, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake TRD.

J Autoimmun. 2019 Jul;101:86-93. doi: 10.1016/j.jaut.2019.04.008. Epub 2019 Apr 18.

PMID:
31006523
5.

Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation.

Wienke J, Bellutti Enders F, Lim J, Mertens JS, van den Hoogen LL, Wijngaarde CA, Yeo JG, Meyer A, Otten HG, Fritsch-Stork RDE, Kamphuis SSM, Hoppenreijs EPAH, Armbrust W, van den Berg JM, Hissink Muller PCE, Tekstra J, Hoogendijk JE, Deakin CT, de Jager W, van Roon JAG, van der Pol WL, Nistala K, Pilkington C, de Visser M, Arkachaisri T, Radstake TRDJ, van der Kooi AJ, Nierkens S, Wedderburn LR, van Royen-Kerkhof A, van Wijk F.

Arthritis Rheumatol. 2019 Aug;71(8):1377-1390. doi: 10.1002/art.40881. Epub 2019 Mar 12.

6.

Women in Translational Medicine: Tools to Break the Glass Ceiling.

Bots SH, Zuidgeest MGP, Gohar A, Eikendal ALM, Petrelli A, van Os-Medendorp H, van der Schaaf MF, van Sorge NM, van Wijk M, Middendorp S, Speksnijder CM, Klipstein-Grobusch K, Seyfert-Margolis V, Mollema E, van Wijk F, den Ruijter HM.

Front Med (Lausanne). 2018 Dec 13;5:330. doi: 10.3389/fmed.2018.00330. eCollection 2018.

7.

Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.

Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A.

Front Immunol. 2018 Dec 18;9:2951. doi: 10.3389/fimmu.2018.02951. eCollection 2018. Review.

8.

Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis.

Bakker DS, Ariens LFM, van Luijk C, van der Schaft J, Thijs JL, Schuttelaar MLA, van Wijk F, Knol EF, Balak DMW, van Dijk MR, de Bruin-Weller MS.

Br J Dermatol. 2019 May;180(5):1248-1249. doi: 10.1111/bjd.17538. Epub 2019 Feb 4. No abstract available.

9.

PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation.

Petrelli A, Mijnheer G, Hoytema van Konijnenburg DP, van der Wal MM, Giovannone B, Mocholi E, Vazirpanah N, Broen JC, Hijnen D, Oldenburg B, Coffer PJ, Vastert SJ, Prakken BJ, Spierings E, Pandit A, Mokry M, van Wijk F.

J Clin Invest. 2018 Oct 1;128(10):4669-4681. doi: 10.1172/JCI96107. Epub 2018 Aug 2.

10.

Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.

van den Hoogen LL, van Roon JAG, Mertens JS, Wienke J, Lopes AP, de Jager W, Rossato M, Pandit A, Wichers CGK, van Wijk F, Fritsch-Stork RDE, Radstake TRDJ.

Ann Rheum Dis. 2018 Dec;77(12):1810-1814. doi: 10.1136/annrheumdis-2018-213497. Epub 2018 Sep 5.

PMID:
30185417
11.

The elusive case of human intraepithelial T cells in gut homeostasis and inflammation.

Lutter L, Hoytema van Konijnenburg DP, Brand EC, Oldenburg B, van Wijk F.

Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):637-649. doi: 10.1038/s41575-018-0039-0. Review.

PMID:
29973676
12.

Update on research and clinical translation on specific clinical areas from biology to bedside: Unpacking the mysteries of juvenile idiopathic arthritis pathogenesis.

van Loosdregt J, van Wijk F, Prakken B, Vastert B.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):460-475. doi: 10.1016/j.berh.2018.02.003. Epub 2018 Apr 1. Review.

PMID:
29773267
13.

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update.

Lutter L, Spierings J, van Rhijn-Brouwer FCC, van Laar JM, van Wijk F.

Front Immunol. 2018 Apr 20;9:767. doi: 10.3389/fimmu.2018.00767. eCollection 2018. Review.

14.

The full spectrum of human naive T cells.

van den Broek T, Borghans JAM, van Wijk F.

Nat Rev Immunol. 2018 Jun;18(6):363-373. doi: 10.1038/s41577-018-0001-y. Review.

PMID:
29520044
15.

Regarding "Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea".

Mertens JS, de Jong EMGJ, Pandit A, Seyger MMB, Hoppenreijs EPAH, Thurlings RM, Vonk MC, Wienke J, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake TRD.

J Invest Dermatol. 2018 May;138(5):1212-1215. doi: 10.1016/j.jid.2017.11.032. Epub 2017 Dec 12. No abstract available.

PMID:
29246801
16.

Human neonatal thymectomy induces altered B-cell responses and autoreactivity.

van den Broek T, Madi A, Delemarre EM, Schadenberg AWL, Tesselaar K, Borghans JAM, Nierkens S, Redegeld FA, Otten HG, Rossetti M, Albani S, Sorek R, Cohen IR, Jansen NJG, van Wijk F.

Eur J Immunol. 2017 Nov;47(11):1970-1981. doi: 10.1002/eji.201746971. Epub 2017 Sep 6.

17.

Review: Enhancers in Autoimmune Arthritis: Implications and Therapeutic Potential.

Peeters JGC, Vastert SJ, van Wijk F, van Loosdregt J.

Arthritis Rheumatol. 2017 Oct;69(10):1925-1936. doi: 10.1002/art.40194. Review. No abstract available.

18.

Haematopoietic stem cell transplantation for autoimmune diseases.

Swart JF, Delemarre EM, van Wijk F, Boelens JJ, Kuball J, van Laar JM, Wulffraat NM.

Nat Rev Rheumatol. 2017 Apr;13(4):244-256. doi: 10.1038/nrrheum.2017.7. Epub 2017 Feb 23. Review.

PMID:
28228650
19.

The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases.

Smids C, Horjus Talabur Horje CS, van Wijk F, van Lochem EG.

J Crohns Colitis. 2017 Apr 1;11(4):500-508. doi: 10.1093/ecco-jcc/jjw163. Review.

PMID:
27660340
20.

The dorsal nerve of the clitoris in relation to urinary incontinence sling procedures.

van der Walt S, van Wijk FJ, Abdool Z, Oettlé AC.

Int Urogynecol J. 2017 Jan;28(1):119-123. doi: 10.1007/s00192-016-3086-5. Epub 2016 Aug 22.

PMID:
27549222
21.

CD8(+) T cells in human autoimmune arthritis: the unusual suspects.

Petrelli A, van Wijk F.

Nat Rev Rheumatol. 2016 Jul;12(7):421-8. doi: 10.1038/nrrheum.2016.74. Epub 2016 Jun 3. Review.

PMID:
27256711
22.

Autoimmune disease-associated gene expression is reduced by BET-inhibition.

Peeters JG, Vervoort SJ, Mijnheer G, de Roock S, Vastert SJ, Nieuwenhuis EE, van Wijk F, Prakken BJ, Mokry M, van Loosdregt J.

Genom Data. 2015 Nov 7;7:14-7. doi: 10.1016/j.gdata.2015.11.004. eCollection 2016 Mar.

23.

Neonatal thymectomy reveals differentiation and plasticity within human naive T cells.

van den Broek T, Delemarre EM, Janssen WJ, Nievelstein RA, Broen JC, Tesselaar K, Borghans JA, Nieuwenhuis EE, Prakken BJ, Mokry M, Jansen NJ, van Wijk F.

J Clin Invest. 2016 Mar 1;126(3):1126-36. doi: 10.1172/JCI84997. Epub 2016 Feb 22.

24.

Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells.

Delemarre EM, van den Broek T, Mijnheer G, Meerding J, Wehrens EJ, Olek S, Boes M, van Herwijnen MJ, Broere F, van Royen A, Wulffraat NM, Prakken BJ, Spierings E, van Wijk F.

Blood. 2016 Jan 7;127(1):91-101. doi: 10.1182/blood-2015-06-649145. Epub 2015 Oct 19.

PMID:
26480932
25.

The cAMP response element modulator (CREM) regulates TH2 mediated inflammation.

Verjans E, Ohl K, Reiss LK, van Wijk F, Toncheva AA, Wiener A, Yu Y, Rieg AD, Gaertner VD, Roth J, Knol E, Kabesch M, Wagner N, Uhlig S, Martin C, Tenbrock K.

Oncotarget. 2015 Nov 17;6(36):38538-51. doi: 10.18632/oncotarget.6041.

26.

Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression.

Peeters JG, Vervoort SJ, Tan SC, Mijnheer G, de Roock S, Vastert SJ, Nieuwenhuis EE, van Wijk F, Prakken BJ, Creyghton MP, Coffer PJ, Mokry M, van Loosdregt J.

Cell Rep. 2015 Sep 29;12(12):1986-96. doi: 10.1016/j.celrep.2015.08.046. Epub 2015 Sep 17.

27.

Self-Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon-γ Blockade.

Petrelli A, Wehrens EJ, Scholman RC, Prakken BJ, Vastert SJ, van Wijk F.

Arthritis Rheumatol. 2016 Jan;68(1):229-36. doi: 10.1002/art.39418.

28.

The Pudendal Nerve and Its Branches in Relation to Richter's Procedure.

van der Walt S, Oettlé AC, van Wijk FJ.

Gynecol Obstet Invest. 2016;81(3):275-9. doi: 10.1159/000435878. Epub 2015 Jul 24.

PMID:
26227418
29.

Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.

Bulatović Ćalasan M, Vastert SJ, Scholman RC, Verweij F, Klein M, Wulffraat NM, Prakken BJ, van Wijk F.

Rheumatology (Oxford). 2015 Sep;54(9):1724-34. doi: 10.1093/rheumatology/kev101. Epub 2015 Apr 14.

PMID:
25877908
30.

Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of patients with juvenile dermatomyositis correlating with disease activity.

Bellutti Enders F, Delemarre EM, Kuemmerle-Deschner J, van der Torre P, Wulffraat NM, Prakken BP, van Royen-Kerkhof A, van Wijk F.

Ann Rheum Dis. 2015 Jan;74(1):315-7. doi: 10.1136/annrheumdis-2014-206287. Epub 2014 Sep 30. No abstract available.

PMID:
25269830
31.

A sensitive protocol for FOXP3 epigenetic analysis in scarce human samples.

Spreafico R, Rossetti M, van den Broek T, Jansen NJ, Zhang H, Moshref M, Prakken B, van Loosdregt J, van Wijk F, Albani S.

Eur J Immunol. 2014 Oct;44(10):3141-3. doi: 10.1002/eji.201444627. Epub 2014 Aug 25. No abstract available.

32.

Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis.

Bellutti Enders F, van Wijk F, Scholman R, Hofer M, Prakken BJ, van Royen-Kerkhof A, de Jager W.

Arthritis Rheumatol. 2014 Aug;66(8):2281-9. doi: 10.1002/art.38676.

33.

Human dendritic cell functional specialization in steady-state and inflammation.

Boltjes A, van Wijk F.

Front Immunol. 2014 Apr 1;5:131. doi: 10.3389/fimmu.2014.00131. eCollection 2014. Review.

34.

Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment.

Delemarre EM, Roord ST, van den Broek T, Zonneveld-Huijssoon E, de Jager W, Rozemuller H, Martens AC, Broere F, Wulffraat NM, Glant TT, Prakken BJ, van Wijk F.

Arthritis Rheumatol. 2014 Feb;66(2):350-6. doi: 10.1002/art.38261.

35.

Allergen-specific Th2 responses in young children precede sensitization later in life.

Reubsaet LL, Meerding J, Scholman R, Arets B, Prakken BJ, van Wijk F, Knol EF.

Allergy. 2014 Mar;69(3):406-10. doi: 10.1111/all.12366. Epub 2014 Jan 28.

PMID:
24467266
36.

T cell recognition of naturally presented epitopes of self-heat shock protein 70.

de Jong H, Koffeman EC, Meerding JM, Scholman RC, Wieten L, de Jager W, Klein M, Otten H, van Wijk F, van der Zee R, Bijlsma JW, Broere F, van Eden W, Prakken BJ.

Cell Stress Chaperones. 2014 Jul;19(4):569-78. doi: 10.1007/s12192-013-0484-1. Epub 2014 Jan 15.

37.

Mesenchymal stem cell therapy in proteoglycan induced arthritis.

Swart JF, de Roock S, Hofhuis FM, Rozemuller H, van den Broek T, Moerer P, Broere F, van Wijk F, Kuis W, Prakken BJ, Martens AC, Wulffraat NM.

Ann Rheum Dis. 2015 Apr;74(4):769-77. doi: 10.1136/annrheumdis-2013-204147. Epub 2014 Jan 6.

PMID:
24395558
38.

Plasma IL-25 is elevated in a subgroup of patients with clinical reactivity to peanut.

Aalberse JA, van Thuijl AO, Meijer Y, de Jager W, van der Palen-Merkus T, Sprikkelman AB, Hoekstra MO, Prakken BJ, van Wijk F.

Clin Transl Allergy. 2013 Dec 2;3(1):40. doi: 10.1186/2045-7022-3-40.

39.

Differential homeostatic dynamics of human regulatory T-cell subsets following neonatal thymectomy.

Schadenberg AW, van den Broek T, Siemelink MA, Algra SO, de Jong PR, Jansen NJ, Prakken BJ, van Wijk F.

J Allergy Clin Immunol. 2014 Jan;133(1):277-80.e1-6. doi: 10.1016/j.jaci.2013.08.030. Epub 2013 Oct 18. No abstract available.

PMID:
24139831
40.

Plasma chemokines in early wheezers predict the development of allergic asthma.

Reubsaet LL, Meerding J, de Jager W, de Kleer IM, Hoekstra MO, Prakken BJ, van Wijk F, Arets HG.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):1039-40. doi: 10.1164/rccm.201212-2330LE. No abstract available.

PMID:
24127809
41.

Alterations in regulatory T cells induced by specific oligosaccharides improve vaccine responsiveness in mice.

Schijf MA, Kerperien J, Bastiaans J, Szklany K, Meerding J, Hofman G, Boon L, van Wijk F, Garssen J, Van't Land B.

PLoS One. 2013 Sep 20;8(9):e75148. doi: 10.1371/journal.pone.0075148. eCollection 2013.

42.

Anti-tumor necrosis factor α targets protein kinase B/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis.

Wehrens EJ, Vastert SJ, Mijnheer G, Meerding J, Klein M, Wulffraat NM, Prakken BJ, van Wijk F.

Arthritis Rheum. 2013 Dec;65(12):3279-84. doi: 10.1002/art.38132.

43.

Der p 1-induced CD4⁺FOXP3⁺GATA3⁺ T cells have suppressive properties and contribute to the polarization of the TH2-associated response.

Reubsaet L, Meerding J, Giezeman R, de Kleer I, Arets B, Prakken B, Beekman J, van Wijk F.

J Allergy Clin Immunol. 2013 Dec;132(6):1440-44. doi: 10.1016/j.jaci.2013.06.028. Epub 2013 Jul 27. No abstract available.

PMID:
23900057
44.

T cells out of control--impaired immune regulation in the inflamed joint.

Wehrens EJ, Prakken BJ, van Wijk F.

Nat Rev Rheumatol. 2013 Jan;9(1):34-42. doi: 10.1038/nrrheum.2012.149. Review.

PMID:
23390638
45.

Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes.

Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R, Naoe Y, Reis BS, Huang Y, Lambolez F, Docherty M, Attinger A, Shui JW, Kim G, Lena CJ, Sakaguchi S, Miyamoto C, Wang P, Atarashi K, Park Y, Nakayama T, Honda K, Ellmeier W, Kronenberg M, Taniuchi I, Cheroutre H.

Nat Immunol. 2013 Mar;14(3):281-9. doi: 10.1038/ni.2523. Epub 2013 Jan 20.

46.

Editorial: Quality or quantity? Unraveling the role of Treg cells in rheumatoid arthritis.

Prakken B, Ellen Wehrens, van Wijk F.

Arthritis Rheum. 2013 Mar;65(3):552-4. doi: 10.1002/art.37831. No abstract available.

47.

The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics.

Mijnheer G, Prakken BJ, van Wijk F.

Curr Opin Rheumatol. 2013 Mar;25(2):260-7. doi: 10.1097/BOR.0b013e32835d0ee4. Review.

PMID:
23274520
48.

Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.

Zonneveld-Huijssoon E, Albani S, Prakken BJ, van Wijk F.

Clin Exp Immunol. 2013 Jan;171(1):20-9. doi: 10.1111/j.1365-2249.2012.04627.x. Review.

49.

TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis.

Zonneveld-Huijssoon E, van Wijk F, Roord S, Delemarre E, Meerding J, de Jager W, Klein M, Raz E, Albani S, Kuis W, Boes M, Prakken BJ.

Ann Rheum Dis. 2012 Oct;71(10):1706-15. doi: 10.1136/annrheumdis-2011-201131. Epub 2012 May 5.

PMID:
22562976
50.

STAT3 regulates monocyte TNF-alpha production in systemic inflammation caused by cardiac surgery with cardiopulmonary bypass.

de Jong PR, Schadenberg AW, van den Broek T, Beekman JM, van Wijk F, Coffer PJ, Prakken BJ, Jansen NJ.

PLoS One. 2012;7(4):e35070. doi: 10.1371/journal.pone.0035070. Epub 2012 Apr 10.

Supplemental Content

Loading ...
Support Center